Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

C. G. Brunstein, J. N. Barker, D. J. Weisdorf, T. E. DeFor, D. McKenna, S. Y. Chong, J. S. Miller, P. B. McGlave, J. E. Wagner

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Abstract

The time to neutrophil engraftment for adult patients after myeloablative double unit umbilical cord blood (UCB) transplantation is 23 days when the two units are given i.v. We hypothesized that the intra-BM injection (IBMI) of one of the two UCB units would reduce systemic loss of hematopoietic progenitors and shorten time to neutrophil recovery after myeloablation. Ten patients with a median age of 35 years were transplanted. The unit to be given by IBMI was randomly assigned; the other unit was given i.v. The median infused graft total nucleated cell dose was 3.7 × 107/kg with no difference between i.v. and IBMI units. All patients tolerated the procedure well, and there was no severe adverse event related to IBMI. The median time to neutrophil engraftment and plt recovery >50000/μl was 21 and 69 days, respectively. In all, 9 of 10 patients engrafted, 5 with the i.v. unit and 4 with the IBMI unit; 7 of 8 evaluable patients developed acute GVHD and 5 of 10 patients died from treatment-related causes. Survival was 47% at 1 year. Despite safety of administration, IBMI of one of two UCB units did not shorten the time to neutrophil engraftment and offers no advantage over conventional double unit transplantation.

Original languageEnglish (US)
Pages (from-to)935-940
Number of pages6
JournalBone marrow transplantation
Volume43
Issue number12
DOIs
StatePublished - 2009

Bibliographical note

Funding Information:
We thank Marilee Larkin and Kathy Gulberg for their assistance with patient recruiting, clinical monitoring and the execution of the IBMI procedure. This work was supported in part by grants from the National Cancer Institute PO1-CA65493 (JEW, TED), The Children’s Cancer Research Fund (JEW, TED), and the National Marrow Donor Program Prime Award #13468 (JNB)

Fingerprint

Dive into the research topics of 'Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units'. Together they form a unique fingerprint.

Cite this